Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Soligenix Inc (NQ: SNGX )

0.4502 +0.0001 (+0.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 82,309
Open 0.4500
Bid (Size) 0.4500 (252)
Ask (Size) 0.4750 (17)
Prev. Close 0.4501
Today's Range 0.4500 - 0.4700
52wk Range 0.3800 - 0.9999
Shares Outstanding 43,227,288
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga

Performance

YTD
-7.16%
-7.16%
1 Month
-2.13%
-2.13%
3 Month
-29.70%
-29.70%
6 Month
-47.04%
-47.04%
1 Year
-27.06%
-27.06%

More News

Read More
Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Recap: Soligenix Q2 Earnings
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Tuesday Morning Shares Are Trading Lower By 38%; Here Are 31 Stocks Moving Premarket
Via Benzinga
Soligenix Delivers Two Pivotal Milestones
Via NewMediaWire
7 Stocks to Add to Your 10x Watchlist
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Soligenix Positioned for Growth: Late-stage Pipeline and Key Q4 Milestones
Via NewMediaWire
UPDATE: Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat with PCG Advisory
Via NewMediaWire
Exposures Product Safety
Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat With PCG Advisory
Via NewMediaWire
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Soligenix Enters Q4 With Multiple Catalysts in Play
Via NewMediaWire
Exposures Product Safety
11 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
FDA Awards $2.6 Million Grant for Expanded Study of Soligenix's HyBryte for CTCL
Via NewMediaWire
Exposures Product Safety
Soligenix Earnings Perspective: Return On Capital Employed
Via Benzinga
Could This Company's HyBryte™ Provide A Safer, More Convenient Alternative To Cutaneous T-Cell Lymphoma Treatment?
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Via Benzinga
Soligenix's HyBryte Treatment Now Within Reach for Rare Cancer Patients
Via NewMediaWire
Exposures Product Safety
Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.